| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |